HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David Orlicky Selected Research

David Orlicky Research Topics

Disease

2Fibrosis (Cirrhosis)
01/2019 - 01/2018
2Type 2 Diabetes Mellitus (MODY)
01/2018 - 01/2018
2Obesity
01/2018 - 01/2014
1Non-alcoholic Fatty Liver Disease
01/2019
1Fatty Liver
01/2019
1Inflammation (Inflammations)
01/2019
1Biliary Atresia
11/2018
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2018
1Mitochondrial Diseases (Mitochondrial Disease)
01/2018
1Proteinuria
01/2018
1Maternal Obesity
01/2014
1Transitional Cell Carcinoma
06/2002
1Neoplasms (Cancer)
05/2002
1Squamous Intraepithelial Lesions
05/2002
1Papillomavirus Infections
05/2002
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2002
1Uterine Cervical Dysplasia
05/2002

Drug/Important Bio-Agent (IBA)

2LipidsIBA
01/2019 - 01/2014
2SurvivinIBA
06/2002 - 05/2002
1oxidized low density lipoproteinIBA
01/2019
1CholesterolIBA
01/2019
1Dietary Fats (Dietary Fat)IBA
01/2019
1CytokinesIBA
11/2018
16alpha-ethyl-23(S)-methylcholic acidIBA
01/2018
1NAD (NADH)IBA
01/2018
1Oxygen (Dioxygen)IBA
01/2018
1Adenosine Diphosphate (ADP)IBA
01/2018
1Streptozocin (Streptozotocin)FDA Link
01/2018
16-ethyl-24-norcholane-3,7,23-triol-23 sulfateIBA
01/2018
1Fatty Acids (Saturated Fatty Acids)IBA
01/2014
1Acetyl-CoA CarboxylaseIBA
01/2014
1Proteins (Proteins, Gene)FDA Link
06/2002
1Inhibitor of Apoptosis ProteinsIBA
05/2002

Therapy/Procedure

1Hysterectomy
05/2002